Skip to main content
. Author manuscript; available in PMC: 2013 Sep 15.
Published in final edited form as: Cancer Res. 2012 Jul 30;72(18):4733–4743. doi: 10.1158/0008-5472.CAN-12-1639

Figure 2.

Figure 2

DLBCL risk associated with 1-unit (natural log scale) increase in immune marker level (OR and 95% CI), with cases categorized by decreasing lag time between blood draw and diagnosis (circle: 9–13 years; triangle: <3 years).